Aspirin Exacerbated Asthma Completed Phase 2 Trials for Prasugrel (DB06209)

Also known as: Aspirin-sensitive asthma / Asthma Aspirin-sensitive / Asthma, Aspirin-Induced / Aspirin-induced asthma / Aspirin asthma / Aspirin-exacerbated respiratory disease / ASA - Aspirin-sensitive asthma triad

IndicationStatusPhase
DBCOND0057602 (Aspirin Exacerbated Asthma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01597375Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)Supportive Care